R-O5963

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameR-O5963
Drug Alias NameR-O5963
ClassificationOther
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsProtein Mdm4 inhibitors
TargetsProtein Mdm4p53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A